|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.000 GBX | +17.65% |
|
0.00% | -47.37% |
| 07-14 | WINNERS & LOSERS: Ironveld's plant in production; Headlam revenue down | AN |
| 07-08 | WINNERS & LOSERS: Jet2 record passengers; Victoria agrees refinancing | AN |
| Market Cap | 1.42M 1.91M 1.67M 1.54M 2.67M 184M 2.73M 18.39M 7.23M 90M 7.17M 7.01M 310M | P/E 2024 |
-2.47x | P/E 2025 | -3.56x |
|---|---|---|---|---|---|
| Enterprise Value | 1.27M 1.71M 1.49M 1.38M 2.39M 164M 2.45M 16.46M 6.47M 80.55M 6.41M 6.27M 277M | EV / Sales 2024 |
61,809,222x | EV / Sales 2025 | 76,138,323x |
| Free-Float |
80.4% | Yield 2024 * |
-
| Yield 2025 | - |
| 02-06 | BSF : Proxy Form | PU |
| 02-06 | BSF : Notice of AGM | PU |
| 25-03-06 | BSF : Publication of Prospectus | PU |
| 25-03-06 | BSF : Prospectus | PU |
| 25-02-07 | BSF : Proxy Form | PU |
| 1 day | +17.65% | ||
| Current month | -2.44% | ||
| 1 month | -11.11% | ||
| 3 months | -42.86% | ||
| 6 months | -60.40% | ||
| Current year | -47.37% |
| 1 week | 0.72 |  | 1 |
| 1 month | 0.72 | | 1.25 |
| Current year | 0.5 | | 4 |
| 1 year | 0.5 | | 4 |
| 3 years | 0.5 | | 14.84 |
| 5 years | 0.5 | | 23.88 |
| 10 years | 0.5 | | 23.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Che Connon
CEO | Chief Executive Officer | 54 | - |
Graham Duncan
DFI | Director of Finance/CFO | 63 | 2022-06-05 |
Ricardo Gouveia
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Geoffrey Baker
CHM | Chairman | 70 | 2025-12-04 |
Kian Jing Ow
BRD | Director/Board Member | 60 | 2021-08-04 |
Che Connon
BRD | Director/Board Member | 54 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/18/24 | Buy | Chief Financial Officer | 26,000 | 0.0252% | ||
| 6/18/24 | Buy | Chief Financial Officer | 500 | 0.0005% | ||
| 6/18/24 | Buy | Chief Financial Officer | 11,798 | 0.0114% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +17.65% | 0.00% | -50.00% | -91.40% | 1.91M | |
| -0.25% | +1.51% | +23.39% | -6.90% | 68.85B | |
| -0.42% | +1.15% | +37.51% | +190.33% | 52.13B | |
| +0.94% | +39.60% | +39.60% | +39.60% | 43.46B | |
| -0.58% | +1.05% | -51.98% | -53.78% | 41.24B | |
| -1.16% | -2.88% | +65.49% | -26.09% | 30.41B | |
| -1.05% | -8.60% | +97.76% | -50.91% | 24.53B | |
| -0.98% | +1.46% | +72.00% | +81.06% | 23.42B | |
| +3.99% | +3.12% | +3.87% | +200.81% | 19.75B | |
| +0.93% | +0.43% | +72.19% | +126.61% | 16.57B | |
| Average | +1.92% | -1.94% | +30.98% | +40.93% | 32.04B | |
| Weighted average by Cap. | -0.01% | +0.08% | +32.75% | +46.41% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.06 0.08 0.07 0.06 0.11 7.49 0.11 0.75 0.29 3.67 0.29 0.29 12.63 | 0.05 0.07 0.06 0.06 0.1 6.85 0.1 0.69 0.27 3.35 0.27 0.26 11.54 |
| Net income | -1.67M -2.25M -1.97M -1.81M -3.15M -217M -3.22M -21.68M -8.53M -106M -8.45M -8.26M -365M | -1.11M -1.5M -1.31M -1.21M -2.1M -144M -2.15M -14.44M -5.68M -70.66M -5.63M -5.5M -243M |
| Net Debt | -560K -753K -658K -607K -1.05M -72.5M -1.08M -7.26M -2.85M -35.51M -2.83M -2.77M -122M | -149K -200K -175K -162K -281K -19.31M -287K -1.93M -760K -9.46M -753K -736K -32.55M |
Employees
14
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | GBX 1.000 | +17.65% | 1,374,198 |
| 26-07-17 | GBX 0.8500 | -2.86% | 4,681,464 |
| 26-07-16 | GBX 0.8750 | 0.00% | 78,074 |
| 26-07-15 | GBX 0.8750 | 0.00% | 24,159 |
| 26-07-14 | GBX 0.8750 | -12.50% | 3,151,902 |
- Stock Market
- Stocks
- BSFA Stock
Select your edition
All financial news and data tailored to specific country editions
